-
NEW! ONTARIO PRESCRIPTION OPIOID TOOL
Updated March 2021:
Includes data up to November 2020 (January 2021 for naloxone).
-
COVID-19 Research
In line with the our goal of being a leader in generating high-quality, relevant, and timely research, the ODPRN is conducting several projects examining the impacts of the pandemic on medication use and drug safety
-
Updated: COVID-19 Ontario Prescription Drug Utilization Tool
This interactive tool now provides public access to data on drug utilization in Ontario during the COVID-19 pandemic up to October 2020 (November 2020 for opioids and benzodiazepines).
-
Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic
This report describes the circumstances surrounding opioid-related deaths in Ontario during COVID-19. An understanding of these circumstances is needed to inform interventions and policies to prevent further opioid-related mortality during this pandemic.
-
UTILIZATION OF INNOVATOR BIOLOGICS AND BIOSIMILARS IN ONTARIO
This report describes the current and prospective utilization patterns and expenditures of innovator biologics and biosimilars through the public drug program in Ontario.
-
QUALITY. RELEVANCE. TIMELINESS.
The Ontario Drug Policy Research Network (ODPRN) is a province-wide network of researchers who provide timely, high quality, drug policy relevant research to decision makers.
-
PATIENT ENGAGEMENT
Learn about the ODPRN Citizen's Panel and their involvement in research.
-
ODPRN IN THE NEWS
Click to view the latest news stories from leading media outlets highlighting ODPRN research and scientists.